Which of the following is a documented clinical purpose of measurement?

• A. Document baseline status
• B. Determine regulatory status
• C. Monitor adverse events
• D. Estimate population prevalence

Answer: (A)

Measuring a patient’s status at a defined point in time provides a reference point—baseline—that lets clinicians see how the patient changes after an intervention. Establishing baseline status is foundational because it sets the starting line against which future measurements are compared, guiding treatment decisions and helping determine whether a patient has improved, worsened, or remained stable.

Regulatory status is about whether a product or study meets rules and standards, which is not a routine clinical measurement purpose. Monitoring adverse events involves tracking safety over time and can use measurements, but its primary aim is safety surveillance rather than establishing an initial patient state. Estimating population prevalence is an epidemiological goal that describes how common a feature is in a group, not a clinical measurement purpose for an individual patient.